Talkspace (TALK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Mar, 2026Executive summary
Entered into a definitive agreement to be acquired by Universal Health Services (UHS), aiming to create the first nationally scaled, end-to-end behavioral healthcare continuum in the U.S.
The combination leverages UHS's hospital network and Talkspace's technology-driven mental health platform to expand access and integrate care.
The transaction is positioned as a strategic step to improve patient care, drive innovation, and deliver service integration across all levels of behavioral health.
Talkspace will continue to operate as an independent entity and wholly owned subsidiary within UHS's Behavioral Health Division.
Communications emphasize operational continuity and ongoing commitment to high-quality clinical outcomes and innovation.
Voting matters and shareholder proposals
Completion of the transaction is subject to approval by Talkspace's stockholders and satisfaction of customary closing conditions, including regulatory approvals.
Proxy materials, including preliminary and definitive proxy statements, will be filed with the SEC for shareholder review and vote.
Shareholders are urged to read all relevant documents filed with the SEC for important information about the proposed transaction.
Board of directors and corporate governance
Directors, executive officers, and certain employees may be deemed participants in the solicitation of proxies for the transaction.
Information about directors and executive officers, including changes in their holdings, will be disclosed in the proxy statement and related SEC filings.
Latest events from Talkspace
- Shareholders to receive $5.25 per share in all-cash merger, pending approvals and clearances.TALK
Proxy Filing9 Mar 2026 - UHS to acquire Talkspace for $835M, expanding virtual behavioral health services nationwide.TALK
Proxy Filing9 Mar 2026 - 2025 revenue up 22% to $229M, adjusted EBITDA up 127%, with strong 2026 growth outlook.TALK
Q4 202519 Feb 2026 - Director elections, auditor ratification, and executive pay were key agenda items.TALK
AGM 20243 Feb 2026 - Q2 revenue up 29%, net loss narrowed, and share repurchase authority expanded to $32M.TALK
Q2 20242 Feb 2026 - Q3 revenue up 23% to $47.4M, net income positive, Payor segment drives growth.TALK
Q3 202418 Jan 2026 - AI-driven solutions and payer partnerships drive growth and position the platform for leadership.TALK
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Profitable, AI-driven behavioral health platform targets 200M covered lives and 25% annual growth.TALK
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Expanding in-network mental health access with AI innovation and targeted market growth.TALK
Barclays 27th Annual Global Healthcare Conference26 Dec 2025